{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T03:06:56Z","timestamp":1790996816003,"version":"4.1.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2018,4,3]],"date-time":"2018-04-03T00:00:00Z","timestamp":1522713600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100002403","name":"Taibah University","doi-asserted-by":"publisher","award":["8014\/437"],"award-info":[{"award-number":["8014\/437"]}],"id":[{"id":"10.13039\/501100002403","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1007\/s10067-018-4080-8","type":"journal-article","created":{"date-parts":[[2018,4,2]],"date-time":"2018-04-02T20:58:01Z","timestamp":1522702681000},"page":"2035-2042","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":134,"title":["Resveratrol as an effective adjuvant therapy in the management of rheumatoid arthritis: a clinical study"],"prefix":"10.1007","volume":"37","author":[{"given":"Hani M.","family":"Khojah","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sameh","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahran S.","family":"Abdel-Rahman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eman H.","family":"Elhakeim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,4,3]]},"reference":[{"issue":"6937","key":"4080_CR1","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1038\/nature01661","volume":"423","author":"GS Firestein","year":"2003","unstructured":"Firestein GS (2003) Evolving concepts of rheumatoid arthritis. Nature 423(6937):356\u2013361. https:\/\/doi.org\/10.1038\/nature01661","journal-title":"Nature"},{"key":"4080_CR2","doi-asserted-by":"publisher","unstructured":"Choy E (2012) Understanding the dynamics: pathways involved in the pathogenesis of rheumatoid arthritis. Rheumatology (Oxford) 51:v3\u2013v11. https:\/\/doi.org\/10.1093\/rheumatology\/kes113","DOI":"10.1093\/rheumatology\/kes113"},{"issue":"8","key":"4080_CR3","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1002\/art.1780310816","volume":"31","author":"T Saxne","year":"1988","unstructured":"Saxne T, Palladino MA Jr, Heinegard D, Talal N, Wollheim FA (1988) Detection of tumor necrosis factor alpha but not tumor necrosis factor beta in rheumatoid arthritis synovial fluid and serum. Arthritis Rheum 31(8):1041\u20131045","journal-title":"Arthritis Rheum"},{"issue":"21","key":"4080_CR4","doi-asserted-by":"publisher","first-page":"2167","DOI":"10.1056\/NEJMra032906","volume":"350","author":"NJ Olsen","year":"2004","unstructured":"Olsen NJ, Stein CM (2004) New drugs for rheumatoid arthritis. N Engl J Med 350(21):2167\u20132179. https:\/\/doi.org\/10.1056\/NEJMra032906","journal-title":"N Engl J Med"},{"key":"4080_CR5","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1111\/j.1749-6632.2010.05842.x","volume":"1215","author":"T Walle","year":"2011","unstructured":"Walle T (2011) Bioavailability of resveratrol. Ann N Y Acad Sci 1215:9\u201315. https:\/\/doi.org\/10.1111\/j.1749-6632.2010.05842.x","journal-title":"Ann N Y Acad Sci"},{"issue":"4","key":"4080_CR6","first-page":"371","volume":"9","author":"PJ Elliott","year":"2008","unstructured":"Elliott PJ, Jirousek M (2008) Sirtuins: novel targets for metabolic disease. Curr Opin Investig Drugs 9(4):371\u2013378","journal-title":"Curr Opin Investig Drugs"},{"issue":"6","key":"4080_CR7","doi-asserted-by":"publisher","first-page":"340","DOI":"10.4078\/jrd.2016.23.6.340","volume":"23","author":"S-J Yoo","year":"2016","unstructured":"Yoo S-J, Go E, Kim Y-E, Lee S, Kwon J (2016) Roles of reactive oxygen species in rheumatoid arthritis pathogenesis. J Rheum Dis 23(6):340\u2013347","journal-title":"J Rheum Dis"},{"issue":"2","key":"4080_CR8","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.neuint.2008.10.008","volume":"54","author":"SS Karuppagounder","year":"2009","unstructured":"Karuppagounder SS, Pinto JT, Xu H, Chen HL, Beal MF, Gibson GE (2009) Dietary supplementation with resveratrol reduces plaque pathology in a transgenic model of Alzheimer\u2019s disease. Neurochem Int 54(2):111\u2013118. https:\/\/doi.org\/10.1016\/j.neuint.2008.10.008","journal-title":"Neurochem Int"},{"issue":"1\u20132","key":"4080_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10753-006-9012-0","volume":"30","author":"N Elmali","year":"2007","unstructured":"Elmali N, Baysal O, Harma A, Esenkaya I, Mizrak B (2007) Effects of resveratrol in inflammatory arthritis. Inflammation 30(1\u20132):1\u20136. https:\/\/doi.org\/10.1007\/s10753-006-9012-0","journal-title":"Inflammation"},{"issue":"1","key":"4080_CR10","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1007\/s00296-010-1598-8","volume":"32","author":"H Nakayama","year":"2012","unstructured":"Nakayama H, Yaguchi T, Yoshiya S, Nishizaki T (2012) Resveratrol induces apoptosis MH7A human rheumatoid arthritis synovial cells in a sirtuin 1-dependent manner. Rheumatol Int 32(1):151\u2013157. https:\/\/doi.org\/10.1007\/s00296-010-1598-8","journal-title":"Rheumatol Int"},{"issue":"2","key":"4080_CR11","doi-asserted-by":"publisher","first-page":"93","DOI":"10.4078\/jrd.2015.22.2.93","volume":"22","author":"C Yun-Hong","year":"2015","unstructured":"Yun-Hong C, Hyun-Ok K, Young-Sun S, Jae Hyung H, Wonyong J, Hye-Song L, Young-Sool H, Mi Jeong S, Dae Young K, Sang-Il L (2015) Inhibitory effects for rheumatoid arthritis of dietary supplementation with resveratrol in collagen-induced arthritis. J Rheum Dis 22(2):93\u2013101","journal-title":"J Rheum Dis"},{"issue":"3","key":"4080_CR12","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1093\/rheumatology\/kem368","volume":"47","author":"HS Byun","year":"2008","unstructured":"Byun HS, Song JK, Kim YR, Piao L, Won M, Park KA, Choi BL, Lee H, Hong JH, Park J, Seok JH, Lee YJ, Kang SW, Hur GM (2008) Caspase-8 has an essential role in resveratrol-induced apoptosis of rheumatoid fibroblast-like synoviocytes. Rheumatology (Oxford) 47(3):301\u2013308. https:\/\/doi.org\/10.1093\/rheumatology\/kem368","journal-title":"Rheumatology (Oxford)"},{"issue":"1","key":"4080_CR13","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1136\/ard.2011.149831","volume":"71","author":"G Xuzhu","year":"2012","unstructured":"Xuzhu G, Komai-Koma M, Leung BP, Howe HS, McSharry C, McInnes IB, Xu D (2012) Resveratrol modulates murine collagen-induced arthritis by inhibiting Th17 and B-cell function. Ann Rheum Dis 71(1):129\u2013135. https:\/\/doi.org\/10.1136\/ard.2011.149831","journal-title":"Ann Rheum Dis"},{"key":"4080_CR14","doi-asserted-by":"publisher","unstructured":"Almeida L, Vaz-da-Silva M, Falcao A, Soares E, Costa R, Loureiro AI, Fernandes-Lopes C, Rocha JF, Nunes T, Wright L, Soares-da-Silva P (2009) Pharmacokinetic and safety profile of trans-resveratrol in a rising multiple-dose study in healthy volunteers. Mol Nutr Food Res 53:S7\u2013S15. https:\/\/doi.org\/10.1002\/mnfr.200800177","DOI":"10.1002\/mnfr.200800177"},{"issue":"1","key":"4080_CR15","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1002\/mnfr.200900437","volume":"54","author":"CH Cottart","year":"2010","unstructured":"Cottart CH, Nivet-Antoine V, Laguillier-Morizot C, Beaudeux JL (2010) Resveratrol bioavailability and toxicity in humans. Mol Nutr Food Res 54(1):7\u201316. https:\/\/doi.org\/10.1002\/mnfr.200900437","journal-title":"Mol Nutr Food Res"},{"issue":"3","key":"4080_CR16","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1002\/art.1780310302","volume":"31","author":"FC Arnett","year":"1988","unstructured":"Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, Healey LA, Kaplan SR, Liang MH, Luthra HS et al (1988) The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31(3):315\u2013324","journal-title":"Arthritis Rheum"},{"key":"4080_CR17","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.exger.2014.05.015","volume":"57","author":"SD Anton","year":"2014","unstructured":"Anton SD, Embry C, Marsiske M, Lu X, Doss H, Leeuwenburgh C, Manini TM (2014) Safety and metabolic outcomes of resveratrol supplementation in older adults: results of a twelve-week, placebo-controlled pilot study. Exp Gerontol 57:181\u2013187. https:\/\/doi.org\/10.1016\/j.exger.2014.05.015","journal-title":"Exp Gerontol"},{"issue":"1","key":"4080_CR18","doi-asserted-by":"publisher","first-page":"4368","DOI":"10.2903\/j.efsa.2016.4368","volume":"14","author":"Efsa Panel on Dietetic Products N, Allergies","year":"2016","unstructured":"Efsa Panel on Dietetic Products N, Allergies (2016) Safety of synthetic trans-resveratrol as a novel food pursuant to Regulation (EC) No 258\/97. EFSA J 14(1):4368\u20134397. https:\/\/doi.org\/10.2903\/j.efsa.2016.4368","journal-title":"EFSA J"},{"key":"4080_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.arr.2015.01.002","volume":"21","author":"MG Novelle","year":"2015","unstructured":"Novelle MG, Wahl D, Dieguez C, Bernier M, de Cabo R (2015) Resveratrol supplementation: where are we now and where should we go? Ageing Res Rev 21:1\u201315. https:\/\/doi.org\/10.1016\/j.arr.2015.01.002","journal-title":"Ageing Res Rev"},{"key":"4080_CR20","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1155\/2014\/248635","volume":"2014","author":"G Singh","year":"2014","unstructured":"Singh G, Pai RS (2014) A rapid reversed-phase HPLC method for analysis of trans-resveratrol in PLGA nanoparticulate formulation. ISRN Chromatography 2014:6. https:\/\/doi.org\/10.1155\/2014\/248635","journal-title":"ISRN Chromatography"},{"issue":"8 Pt 1","key":"4080_CR21","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1093\/clinchem\/41.8.1121","volume":"41","author":"LJ Sokoll","year":"1995","unstructured":"Sokoll LJ, O\u2019Brien ME, Camilo ME, Sadowski JA (1995) Undercarboxylated osteocalcin and development of a method to determine vitamin K status. Clin Chem 41(8 Pt 1):1121\u20131128","journal-title":"Clin Chem"},{"issue":"1\u20132","key":"4080_CR22","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/0009-8981(92)90105-Y","volume":"211","author":"K Obata","year":"1992","unstructured":"Obata K, Iwata K, Okada Y, Kohrin Y, Ohuchi E, Yoshida S, Shinmei M, Hayakawa T (1992) A one-step sandwich enzyme immunoassay for human matrix metalloproteinase 3 (stromelysin-1) using monoclonal antibodies. Clin Chim Acta 211(1\u20132):59\u201372","journal-title":"Clin Chim Acta"},{"issue":"3","key":"4080_CR23","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1385\/MO:22:3:241","volume":"22","author":"F Tas","year":"2005","unstructured":"Tas F, Oguz H, Argon A, Duranyildiz D, Camlica H, Yasasever V, Topuz E (2005) The value of serum levels of IL-6, TNF-alpha, and erythropoietin in metastatic malignant melanoma: serum IL-6 level is a valuable prognostic factor at least as serum LDH in advanced melanoma. Med Oncol 22(3):241\u2013246. https:\/\/doi.org\/10.1385\/mo:22:3:241","journal-title":"Med Oncol"},{"issue":"9","key":"4080_CR24","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1136\/ard.2006.063834","volume":"66","author":"T Matsui","year":"2007","unstructured":"Matsui T, Kuga Y, Kaneko A, Nishino J, Eto Y, Chiba N, Yasuda M, Saisho K, Shimada K, Tohma S (2007) Disease Activity Score 28 (DAS28) using C-reactive protein underestimates disease activity and overestimates EULAR response criteria compared with DAS28 using erythrocyte sedimentation rate in a large observational cohort of rheumatoid arthritis patients in Japan. Ann Rheum Dis 66(9):1221\u20131226. https:\/\/doi.org\/10.1136\/ard.2006.063834","journal-title":"Ann Rheum Dis"},{"key":"4080_CR25","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.ejphar.2015.06.014","volume":"761","author":"MS Abdel-Rahman","year":"2015","unstructured":"Abdel-Rahman MS, Alkady EA, Ahmed S (2015) Menaquinone-7 as a novel pharmacological therapy in the treatment of rheumatoid arthritis: a clinical study. Eur J Pharmacol 761:273\u2013278. https:\/\/doi.org\/10.1016\/j.ejphar.2015.06.014","journal-title":"Eur J Pharmacol"},{"key":"4080_CR26","first-page":"S93","volume":"23","author":"J Fransen","year":"2005","unstructured":"Fransen J, van Riel PL (2005) The Disease Activity Score and the EULAR response criteria. Clin Exp Rheumatol 23:S93\u2013S99","journal-title":"Clin Exp Rheumatol"},{"key":"4080_CR27","doi-asserted-by":"publisher","DOI":"10.1038\/s41698-017-0038-6","volume":"1","author":"AY Berman","year":"2017","unstructured":"Berman AY, Motechin RA, Wiesenfeld MY, Holz MK (2017) The therapeutic potential of resveratrol: a review of clinical trials. NPJ Precis Oncol 1:35. https:\/\/doi.org\/10.1038\/s41698-017-0038-6","journal-title":"NPJ Precis Oncol"},{"key":"4080_CR28","doi-asserted-by":"publisher","unstructured":"Wahab A, Gao K, Jia C, Zhang F, Tian G, Murtaza G, Chen J (2017) Significance of resveratrol in clinical management of chronic diseases. Molecules 22(8). https:\/\/doi.org\/10.3390\/molecules22081329","DOI":"10.3390\/molecules22081329"},{"issue":"1","key":"4080_CR29","doi-asserted-by":"publisher","first-page":"295","DOI":"10.3892\/etm.2016.3958","volume":"13","author":"M Theodotou","year":"2017","unstructured":"Theodotou M, Fokianos K, Mouzouridou A, Konstantinou C, Aristotelous A, Prodromou D, Chrysikou A (2017) The effect of resveratrol on hypertension: a clinical trial. Exp Ther Med 13(1):295\u2013301. https:\/\/doi.org\/10.3892\/etm.2016.3958","journal-title":"Exp Ther Med"},{"key":"4080_CR30","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/j.biopha.2017.08.070","volume":"95","author":"E Ozturk","year":"2017","unstructured":"Ozturk E, Arslan AKK, Yerer MB, Bishayee A (2017) Resveratrol and diabetes: a critical review of clinical studies. Biomed Pharmacother 95:230\u2013234. https:\/\/doi.org\/10.1016\/j.biopha.2017.08.070","journal-title":"Biomed Pharmacother"},{"key":"4080_CR31","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.phrs.2017.12.033","volume":"129","author":"F Haghighatdoost","year":"2018","unstructured":"Haghighatdoost F, Hariri M (2018) Effect of resveratrol on lipid profile: an updated systematic review and meta-analysis on randomized clinical trials. Pharmacol Res 129:141\u2013150. https:\/\/doi.org\/10.1016\/j.phrs.2017.12.033","journal-title":"Pharmacol Res"},{"key":"4080_CR32","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.micpath.2017.11.062","volume":"114","author":"L Qiang","year":"2017","unstructured":"Qiang L, Di Y, Jiang Z, Xu J (2017) Resveratrol improves efficacy of oral amoxicillin against childhood fast breathing pneumonia in a randomized placebo-controlled double blind clinical trial. Microb Pathog 114:209\u2013212. https:\/\/doi.org\/10.1016\/j.micpath.2017.11.062","journal-title":"Microb Pathog"},{"issue":"4","key":"4080_CR33","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1210\/js.2017-00053","volume":"1","author":"D Mendes da Silva","year":"2017","unstructured":"Mendes da Silva D, Gross LA, Neto EPG, Lessey BA, Savaris RF (2017) The use of resveratrol as an adjuvant treatment of pain in endometriosis: a randomized clinical trial. J Endocr Soc 1(4):359\u2013369. https:\/\/doi.org\/10.1210\/js.2017-00053","journal-title":"J Endocr Soc"},{"issue":"4","key":"4080_CR34","doi-asserted-by":"publisher","first-page":"456","DOI":"10.3109\/00365521.2015.1107620","volume":"51","author":"S Heeboll","year":"2016","unstructured":"Heeboll S, Kreuzfeldt M, Hamilton-Dutoit S, Kjaer Poulsen M, Stodkilde-Jorgensen H, Moller HJ, Jessen N, Thorsen K, Kristina Hellberg Y, Bonlokke Pedersen S, Gronbaek H (2016) Placebo-controlled, randomised clinical trial: high-dose resveratrol treatment for non-alcoholic fatty liver disease. Scand J Gastroenterol 51(4):456\u2013464. https:\/\/doi.org\/10.3109\/00365521.2015.1107620","journal-title":"Scand J Gastroenterol"},{"issue":"8","key":"4080_CR35","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1001\/jamacardio.2017.0538","volume":"2","author":"MM McDermott","year":"2017","unstructured":"McDermott MM, Leeuwenburgh C, Guralnik JM, Tian L, Sufit R, Zhao L, Criqui MH, Kibbe MR, Stein JH, Lloyd-Jones D, Anton SD, Polonsky TS, Gao Y, de Cabo R, Ferrucci L (2017) Effect of resveratrol on walking performance in older people with peripheral artery disease: the RESTORE randomized clinical trial. JAMA Cardiol 2(8):902\u2013907. https:\/\/doi.org\/10.1001\/jamacardio.2017.0538","journal-title":"JAMA Cardiol"},{"issue":"9426","key":"4080_CR36","doi-asserted-by":"publisher","first-page":"2015","DOI":"10.1016\/S0140-6736(04)16449-0","volume":"363","author":"DW McCarey","year":"2004","unstructured":"McCarey DW, McInnes IB, Madhok R, Hampson R, Scherbakov O, Ford I, Capell HA, Sattar N (2004) Trial of atorvastatin in rheumatoid arthritis (TARA): double-blind, randomised placebo-controlled trial. Lancet 363(9426):2015\u20132021. https:\/\/doi.org\/10.1016\/s0140-6736(04)16449-0","journal-title":"Lancet"},{"key":"4080_CR37","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.e4230","volume":"345","author":"D Giuseppe Di","year":"2012","unstructured":"Di Giuseppe D, Alfredsson L, Bottai M, Askling J, Wolk A (2012) Long term alcohol intake and risk of rheumatoid arthritis in women: a population based cohort study. BMJ 345:e4230. https:\/\/doi.org\/10.1136\/bmj.e4230","journal-title":"BMJ"},{"issue":"4","key":"4080_CR38","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1002\/art.1780360409","volume":"36","author":"DH Manicourt","year":"1993","unstructured":"Manicourt DH, Triki R, Fukuda K, Devogelaer JP, Nagant de Deuxchaisnes C, Thonar EJ (1993) Levels of circulating tumor necrosis factor alpha and interleukin-6 in patients with rheumatoid arthritis. Relationship to serum levels of hyaluronan and antigenic keratan sulfate. Arthritis Rheum 36(4):490\u2013499","journal-title":"Arthritis Rheum"},{"issue":"22","key":"4080_CR39","doi-asserted-by":"publisher","first-page":"9003","DOI":"10.1158\/0008-5472.CAN-10-2364","volume":"70","author":"VA Brown","year":"2010","unstructured":"Brown VA, Patel KR, Viskaduraki M, Crowell JA, Perloff M, Booth TD, Vasilinin G, Sen A, Schinas AM, Piccirilli G, Brown K, Steward WP, Gescher AJ, Brenner DE (2010) Repeat dose study of the cancer chemopreventive agent resveratrol in healthy volunteers: safety, pharmacokinetics, and effect on the insulin-like growth factor axis. Cancer Res 70(22):9003\u20139011. https:\/\/doi.org\/10.1158\/0008-5472.can-10-2364","journal-title":"Cancer Res"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10067-018-4080-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-018-4080-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-018-4080-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,30]],"date-time":"2020-10-30T17:14:44Z","timestamp":1604078084000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10067-018-4080-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4,3]]},"references-count":39,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2018,8]]}},"alternative-id":["4080"],"URL":"https:\/\/doi.org\/10.1007\/s10067-018-4080-8","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,4,3]]},"assertion":[{"value":"21 February 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 March 2018","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 March 2018","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 April 2018","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}},{"value":"All RA patients participated in the study gave informed consent and ethical approval for the study was obtained by Institutional Review Board of the Faculty of Medicine at Assiut University.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}]}}